Novo Nordisk chair and directors exit after row with shareholder

All NewsOctober 21, 2025

Chair and six directors to leave as Danish drugmaker grapples with slowing growth and falling share price

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT

Manage consent